亚太临床参考实验室市场预测至 2031 年 - 区域分析 - 按服务提供商(基于医院、独立和基于诊所)和应用(实验室医学、临床试验和其他)

Historic Data: 2021-2022   |   Base Year: 2023   |   Forecast Period: 2024-2031

Analysis - by Service Provider (Hospital-Based, Standalone, and Clinic-Based) and Application (Laboratory Medicine, Clinical Trials, and Others)


No. of Pages: 93    |    Report Code: BMIRE00030828    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Asia Pacific Clinical Reference Laboratory Market
2023 年亚太临床参考实验室市场价值为 98.1413 亿美元,预计到 2031 年将达到 165.1017 亿美元;预计 2023 年至 2031 年的复合年增长率为 6.7%。

与参考实验室的战略举措推动亚太临床参考实验室市场发展

实验室服务提供商的战略举措,例如收购、联盟和与参考实验室的扩张,是获得更好的患者护理和成本效率最具成本效益的方式之一。2024 年,泰国领先的体外诊断 (IVD) 产品供应商 Hausen-Bernstein Co. Ltd. 被 Everlife Holdings Pte Ltd 收购,后者是印度和东南亚著名的市场准入和分销企业。 2024 年,总部位于印度的新一代药物选择和疾病分层诊断公司 CORE Diagnostics 宣布计划在 50 个新城市扩展业务。2023 年,Suburban Diagnostics 在孟买 Vidya Vihar 开设了其最大的“参考”实验室。这个超现代的实验室将利用最先进的测试和过程自动化技术,提供全面的测试菜单,以实现准确和快速的诊断。2023 年,印度海得拉巴的临床参考实验室 TRUSTlab Diagnostics 与古尔冈的 NKV Path Labs 合作,将其诊断服务扩展到该国服务不足的地区。因此,越来越多的收购和与参考实验室的联盟预计将为市场增长提供重大机会。

亚太临床参考实验室市场概览

近几十年来,包括 COVID-19 和猴痘在内的几种传染病的出现对人类健康构成了新的风险。中国经历了流行病学的快速变化,传染病控制取得了显著进展。在处理传染病问题时,至关重要的是尽快发现和定位疫情,确定病原体,并确保妥善处置,以尽量减少升级并预防和管理传染病。医院或参考实验室进行各种测试以检测病原体。根据省级行政区划 (PLAD),2014 年至 2021 年期间记录了 5,770 例疟疾病例,其中 99.05% 的疟疾样本提交给省级疟疾诊断参考实验室。省级疟疾诊断参考实验室在保证医疗机构疟原虫诊断的准确性和可靠性方面发挥了关键作用。上述因素正在推动该国临床参考实验室市场的发展。

亚太临床参考实验室市场收入及预测至 2031 年(百万美元)

亚太临床参考实验室市场细分

亚太临床参考实验室市场分为服务提供商、应用和国家。

根据服务提供商,亚太临床参考实验室市场分为基于医院、独立和基于诊所。基于医院的细分市场在 2023 年占据最大市场份额。

在应用方面,亚太临床参考实验室市场分为实验室医学、临床试验和其他。实验室医学细分市场在 2023 年占据最大市场份额。

按国家/地区划分,亚太临床参考实验室市场分为中国、日本、印度、澳大利亚、韩国和亚太地区其他地区。 2023 年,中国占据了亚太临床参考实验室市场的主导份额。

Sonic Healthcare Ltd、Laboratory Corp of America Holdings、Quest Diagnostics Inc 和 Myraid Genetics Inc 是亚太临床参考实验室市场的一些领先公司。

Asia Pacific Clinical Reference Laboratory Strategic Insights

Strategic insights for Asia Pacific Clinical Reference Laboratory involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/asia-pacific-clinical-reference-laboratory-market-strategic-framework.webp
Get more information on this report

Asia Pacific Clinical Reference Laboratory Report Scope

Report Attribute Details
Market size in 2023 US$ 9,814.13 Million
Market Size by 2031 US$ 16,510.17 Million
Global CAGR (2023 - 2031) 6.7%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By 服务提供商
  • 医院型
  • 独立型
  • 诊所型
By 应用
  • 实验室医学
  • 临床试验
Regions and Countries Covered 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
Market leaders and key company profiles
  • Sonic Healthcare Ltd
  • Laboratory Corp of America Holdings
  • Quest Diagnostics Inc
  • Myraid Genetics Inc
  • Get more information on this report

    Asia Pacific Clinical Reference Laboratory Regional Insights

    The regional scope of Asia Pacific Clinical Reference Laboratory refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/asia-pacific-clinical-reference-laboratory-market-geography.webp
    Get more information on this report

    The List of Companies - Asia Pacific Clinical Reference Laboratory Market

    1. Sonic Healthcare Ltd
    2. Laboratory Corp of America Holdings
    3. Quest Diagnostics Inc
    4. Myraid Genetics Inc
    Frequently Asked Questions
    How big is the Asia Pacific Clinical Reference Laboratory Market?

    The Asia Pacific Clinical Reference Laboratory Market is valued at US$ 9,814.13 Million in 2023, it is projected to reach US$ 16,510.17 Million by 2031.

    What is the CAGR for Asia Pacific Clinical Reference Laboratory Market by (2023 - 2031)?

    As per our report Asia Pacific Clinical Reference Laboratory Market, the market size is valued at US$ 9,814.13 Million in 2023, projecting it to reach US$ 16,510.17 Million by 2031. This translates to a CAGR of approximately 6.7% during the forecast period.

    What segments are covered in this report?

    The Asia Pacific Clinical Reference Laboratory Market report typically cover these key segments-

  • 服务提供商 (医院型, 独立型, 诊所型)
  • 应用 (实验室医学, 临床试验)
  • What is the historic period, base year, and forecast period taken for Asia Pacific Clinical Reference Laboratory Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Asia Pacific Clinical Reference Laboratory Market report:

  • Historic Period : 2021-2022
  • Base Year : 2023
  • Forecast Period : 2024-2031
  • Who are the major players in Asia Pacific Clinical Reference Laboratory Market?

    The Asia Pacific Clinical Reference Laboratory Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Sonic Healthcare Ltd
  • Laboratory Corp of America Holdings
  • Quest Diagnostics Inc
  • Myraid Genetics Inc
  • Who should buy this report?

    The Asia Pacific Clinical Reference Laboratory Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Asia Pacific Clinical Reference Laboratory Market value chain can benefit from the information contained in a comprehensive market report.